Filing Details

Accession Number:
0001127602-16-042299
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-19 07:31:24
Reporting Period:
2016-02-16
Filing Date:
2016-02-19
Accepted Time:
2016-02-19 07:31:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1141720 F Thomas Ackerman 251 Ballardvale Street
Wilmington MA 01887
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-02-16 200 $74.21 113,698 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.23 113,598 No 4 S Direct
Common Stock Disposition 2016-02-16 200 $74.26 113,398 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.27 113,298 No 4 S Direct
Common Stock Disposition 2016-02-16 300 $74.31 112,998 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.33 112,898 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.34 112,798 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.35 112,698 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.36 112,598 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.40 112,498 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.41 112,398 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.45 112,298 No 4 S Direct
Common Stock Disposition 2016-02-16 400 $74.49 111,898 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.53 111,798 No 4 S Direct
Common Stock Disposition 2016-02-16 100 $74.55 111,698 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale occurred pursuant to a 10b5-1 Trading Plan.